Sublingual Buprenorphine Is Associated with Increased Caries Experience and Altered Oral Microbial and Salivary Risk Factors

Background: Sublingual buprenorphine (SLB) is commonly prescribed to treat opioid use disorder. Pharmacoepidemiologic studies suggest an association between SLB and severe dental caries, yet clinical investigations are lacking. Objective: To assess caries experience and caries-related risk factors among patients taking SLB. Methods: This pilot cross-sectional study enrolled 11 subjects taking SLB films, 10 taking SLB tablets, and 10 age- and sex-matched controls. Demographic, medical, dental, and behavioral data were collected. Caries examinations were performed. Salivary pH, buffering capacity, and flow rate were measured. Saliva and plaque levels of Mutans streptococci and Candida spp. were determined. Oral pH dynamics and salivary concentrations of buprenorphine, its metabolites, and naloxone were monitored. Results: Caries experience was greater in SLB subjects than controls and higher among tablet versus film subjects (p<0.05). SLB subjects exhibited lower salivary pH and buffering capacity (p<0.05), and elevated salivary levels of Mutans streptococci (p<0.05) and Candida spp. (p<0.001). SLB administration was associated with rapid oral acidification and prolonged recovery. Salivary buprenorphine exposure was elevated and correlated with baseline pH (p<0.01), suggesting ion trapping contributes to oral retention. Conclusion: Patients receiving SLB exhibit increased caries experience likely resulting from localized acidification favoring caries-associated microorganisms and prolonged oral exposure to buprenorphine.

Authors

Institutions

Publication Details

Journal
medRxiv
Published
2026-11-16
DOI
https://doi.org/10.64898/2026.11.13.26368056
Primary Topic
Dental Health and Care Utilization
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Sublingual Buprenorphine Is Associated with Increased Caries Experience and Altered Oral Microbial and Salivary Risk Factors

Jacqueline Abranches, Christopher R. McCurdy, Bruna Albuquerque Garcia, Shu-Hao Hsu et al.
medRxiv
Dental Health and Care Utilization
preprint

Sublingual Buprenorphine Is Associated with Increased Caries Experience and Altered Oral Microbial and Salivary Risk Factors

Jacqueline Abranches, Christopher R. McCurdy, Bruna Albuquerque Garcia, Shu-Hao Hsu, Abhisheak Sharma, Callahan Katrak, Dayane Carvalho Ramos Salles de Oliveira, R. Jenkins, Sydney A. M. Reed, Kyra Martin, Yanan Zang, K.V. Kasparian, John Abernethy
preprint en

Abstract

Background: Sublingual buprenorphine (SLB) is commonly prescribed to treat opioid use disorder. Pharmacoepidemiologic studies suggest an association between SLB and severe dental caries, yet clinical investigations are lacking. Objective: To assess caries experience and caries-related risk factors among patients taking SLB. Methods: This pilot cross-sectional study enrolled 11 subjects taking SLB films, 10 taking SLB tablets, and 10 age- and sex-matched controls. Demographic, medical, dental, and behavioral data were collected. Caries examinations were performed. Salivary pH, buffering capacity, and flow rate were measured. Saliva and plaque levels of Mutans streptococci and Candida spp. were determined. Oral pH dynamics and salivary concentrations of buprenorphine, its metabolites, and naloxone were monitored. Results: Caries experience was greater in SLB subjects than controls and higher among tablet versus film subjects (p<0.05). SLB subjects exhibited lower salivary pH and buffering capacity (p<0.05), and elevated salivary levels of Mutans streptococci (p<0.05) and Candida spp. (p<0.001). SLB administration was associated with rapid oral acidification and prolonged recovery. Salivary buprenorphine exposure was elevated and correlated with baseline pH (p<0.01), suggesting ion trapping contributes to oral retention. Conclusion: Patients receiving SLB exhibit increased caries experience likely resulting from localized acidification favoring caries-associated microorganisms and prolonged oral exposure to buprenorphine.

medRxiv
University of Florida (US), Meridian Behavioral Healthcare (US)
Dental Health and Care Utilization
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon